Abstract:
Objective To investigates the expression of miR-222 and TIMP3 in gastric cancer, as well as their clinical significance.
Methods In situ hybridization and immunohistochemistry were used to detect the expression of miR-222 and TIMP3 in gastric cancer specimens, respectively.The correlations among the miR-222, TIMP3 protein, and clinicopathological parameters of gastric cancer were analyzed.
Results In situ hybridization showed that the positive expression rate of miR-222 was 86.67 % and 22.58%in gastric cancer and the adjacent tissue, respectively.In the assay of immunohistochemistry, the positive expression rate of TIMP3 was 19.35 % and 75.81 % in gastric cancer and the adjacent tissue, respectively.Significant differences(P < 0.01) were found between the two aforementioned groups.The correlation analysis indicated that the expression of miR-222 had a close negative correlation with that of TIMP3 in gastric cancer(P < 0.01).The up-regulation of miR-222 expression was associated with an advanced clinical stage, infiltrating depth, and lymph node metastasis in the cancer(P < 0.01).Conversely, the down-regulation of the TIMP3 expression was associated with an advanced clinical stage, infiltrating depth, and lymph node metastasis in the cancer(P < 0.01).
Conclusion The high expression of miR-222 and the low expression of the TIMP3 protein may be important biological markers for malignant transformation in the invasion and metastasis of gastric cancer.The detection of miR-222 and TIMP3 expression in gastric cancer is significantly important for improving the prediction of invasion and metastasis.